Cargando…

Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding

Extranodal natural killer/T-cell lymphoma (ENKTCL) is a rare form of non-Hodgkin lymphoma. This neoplasm is more prevalent in regions of Asia and Latin America and most commonly involves the sinonasal tract, presenting with signs of nasal obstruction, epistaxis, or sinus infection. It is a locally d...

Descripción completa

Detalles Bibliográficos
Autores principales: Althoff, Ashley, Bibliowicz, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476476/
https://www.ncbi.nlm.nih.gov/pubmed/28652944
http://dx.doi.org/10.7759/cureus.1260
_version_ 1783244605649584128
author Althoff, Ashley
Bibliowicz, Michael
author_facet Althoff, Ashley
Bibliowicz, Michael
author_sort Althoff, Ashley
collection PubMed
description Extranodal natural killer/T-cell lymphoma (ENKTCL) is a rare form of non-Hodgkin lymphoma. This neoplasm is more prevalent in regions of Asia and Latin America and most commonly involves the sinonasal tract, presenting with signs of nasal obstruction, epistaxis, or sinus infection. It is a locally destructive and angioinvasive neoplasm. The treatment of ENKTCL is dependent on the extent of the tumor. For localized disease, the treatment is chemoradiation. For disseminated disease, treatment is mainly chemotherapy-based. This report describes a case of a 41-year-old Hispanic woman who initially presented with signs of nasal congestion for four weeks and was subsequently diagnosed and treated for chronic sinusitis. The patient underwent endoscopic surgery for persistent chronic sinusitis, with a presumptive diagnosis of allergic fungal rhinosinusitis based on clinical and radiographic presentation. The pathologic exam revealed a diagnosis of ENKTCL. The patient underwent three cycles of chemotherapy comprised of steroid (hydrocortisone), methotrexate, ifosfamide, pre-asparaginase, and etoposide (SMILE) followed by radiation, resulting in clinical and radiographic remission. On review of the literature, ENKTCL is very rare in the United States and diagnosis is commonly delayed due to non-specific signs. We report this case to increase awareness of this disease entity and remind clinicians to include this in the differential diagnosis of nasal obstruction. 
format Online
Article
Text
id pubmed-5476476
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-54764762017-06-26 Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding Althoff, Ashley Bibliowicz, Michael Cureus Oncology Extranodal natural killer/T-cell lymphoma (ENKTCL) is a rare form of non-Hodgkin lymphoma. This neoplasm is more prevalent in regions of Asia and Latin America and most commonly involves the sinonasal tract, presenting with signs of nasal obstruction, epistaxis, or sinus infection. It is a locally destructive and angioinvasive neoplasm. The treatment of ENKTCL is dependent on the extent of the tumor. For localized disease, the treatment is chemoradiation. For disseminated disease, treatment is mainly chemotherapy-based. This report describes a case of a 41-year-old Hispanic woman who initially presented with signs of nasal congestion for four weeks and was subsequently diagnosed and treated for chronic sinusitis. The patient underwent endoscopic surgery for persistent chronic sinusitis, with a presumptive diagnosis of allergic fungal rhinosinusitis based on clinical and radiographic presentation. The pathologic exam revealed a diagnosis of ENKTCL. The patient underwent three cycles of chemotherapy comprised of steroid (hydrocortisone), methotrexate, ifosfamide, pre-asparaginase, and etoposide (SMILE) followed by radiation, resulting in clinical and radiographic remission. On review of the literature, ENKTCL is very rare in the United States and diagnosis is commonly delayed due to non-specific signs. We report this case to increase awareness of this disease entity and remind clinicians to include this in the differential diagnosis of nasal obstruction.  Cureus 2017-05-19 /pmc/articles/PMC5476476/ /pubmed/28652944 http://dx.doi.org/10.7759/cureus.1260 Text en Copyright © 2017, Althoff et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Althoff, Ashley
Bibliowicz, Michael
Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
title Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
title_full Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
title_fullStr Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
title_full_unstemmed Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
title_short Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
title_sort extranodal natural killer/t-cell lymphoma: an incidental finding
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476476/
https://www.ncbi.nlm.nih.gov/pubmed/28652944
http://dx.doi.org/10.7759/cureus.1260
work_keys_str_mv AT althoffashley extranodalnaturalkillertcelllymphomaanincidentalfinding
AT bibliowiczmichael extranodalnaturalkillertcelllymphomaanincidentalfinding